How and when to refer patients for oncogenetic counseling in the era of PARP inhibitors

MLA

Pascaline Berthet, et al. “How and When to Refer Patients for Oncogenetic Counseling in the Era of PARP Inhibitors.” Therapeutic Advances in Medical Oncology, vol. 12, Jan. 2020, p. 175883591989753. EBSCOhost, https://doi.org/10.1177/1758835919897530.

APA

Pascaline Berthet, Florence Joly, Alison Claire Johnson, Anne Floquet, Zoé Neviere, & Thibault De La Motte Rouge. (2020). How and when to refer patients for oncogenetic counseling in the era of PARP inhibitors. Therapeutic Advances in Medical Oncology, 12, 175883591989753. https://doi.org/10.1177/1758835919897530

Chicago

Pascaline Berthet, Florence Joly, Alison Claire Johnson, Anne Floquet, Zoé Neviere, and Thibault De La Motte Rouge. 2020. “How and When to Refer Patients for Oncogenetic Counseling in the Era of PARP Inhibitors.” Therapeutic Advances in Medical Oncology 12 (January): 175883591989753. doi:10.1177/1758835919897530.